Comorbidity of white matter lesions in parkinson's disease: a study on risk factors and phenotypic differences.
- Published in:
- Neurological Sciences, 2025, v. 46, n. 1, p. 175, doi. 10.1007/s10072-024-07735-x
- By:
- Publication type:
- Article
Works by You, Zhifei
Results: 8
1
2
Sleep disorders in Wilson's disease: a questionnaire study.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 1, p. 209, doi. 10.1007/s10072-022-06401-4
- By:
- Publication type:
- Article
3
Impacts of motor phenotype on cognitive function in patients with Parkinson's disease 1 year after subthalamic‐nucleus deep brain stimulation.
- Published in:
- Geriatrics & Gerontology International, 2023, v. 23, n. 2, p. 85, doi. 10.1111/ggi.14524
- By:
- Publication type:
- Article
4
Assessment of sleep disturbance in patients with Wilson's disease.
- Published in:
- BMC Psychiatry, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12888-024-05493-w
- By:
- Publication type:
- Article
5
Prevalence and Influencing Factors of Depression in Patients with Parkinson’s Disease.
- Published in:
- Alpha Psychiatry, 2023, v. 24, n. 6, p. 234, doi. 10.5152/alphapsychiatry.2023.231253
- By:
- Publication type:
- Article
6
Inside Front Cover.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 9, p. ii, doi. 10.1111/cns.13452
- By:
- Publication type:
- Article
7
Inside Front Cover.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 9, p. ii, doi. 10.1111/cns.13458
- By:
- Publication type:
- Article
8
Efforts of subthalamic nucleus deep brain stimulation on cognitive spectrum: From explicit to implicit changes in the patients with Parkinson's disease for 1 year.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 9, p. 972, doi. 10.1111/cns.13392
- By:
- Publication type:
- Article